Drug pipeline 1Q23-Everything everywhere all over the place

被引：3
|
作者：
Hodgson, John
机构：
来源：
NATURE BIOTECHNOLOGY | 2023年 / 41卷 / 05期
关键词：
D O I：
10.1038/s41587-023-01775-y
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：591 / 593
页数：3
相关论文
共 50 条
  • [41] Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias
    Nilson, I
    Lochner, K
    Siegler, G
    Greil, J
    Beck, JD
    Fey, GH
    Marschalek, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) : 966 - 972
  • [42] Drug development from Australian elapid snake venoms and the Venomics pipeline of candidates for haemostasis: Textilinin-1 (Q8008), Haempatch™ (Q8009) and CoVase™ (V0801)
    Earl, Stephen T. H.
    Masci, Paul P.
    de Jersey, John
    Lavin, Martin F.
    Dixon, Janette
    TOXICON, 2012, 59 (04) : 456 - 463
  • [43] INVOLVEMENT OF THE MLL/ALL-1 GENE ASSOCIATED WITH MULTIPLE POINT MUTATIONS OF THE N-RAS GENE IN ACUTE MYELOID-LEUKEMIA WITH T(11 17)(Q23 Q25)
    NAOE, T
    KUBO, K
    KIYOI, H
    OHNO, R
    AKAO, Y
    YOSHIDA, J
    KATO, K
    KOJIMA, S
    MATSUYAMA, T
    BLOOD, 1993, 82 (07) : 2260 - 2261
  • [44] Real world outcome of B ALL with t (1;19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes
    Panda, Tribikram
    Rainchwar, Sujay
    Singh, Reema
    Singh, Aakanksha
    Soni, Mayank
    Kakkar, Disha
    Jegan, Kr
    Pillai, Reshmi Harikumar
    Palatty, Roy J.
    Jha, Karuna
    Ahmed, Rayaz
    Halder, Rohan
    Tejwani, Narender
    Panda, Devasis
    Bhurani, Dinesh
    Agrawal, Narendra
    LEUKEMIA RESEARCH, 2024, 141
  • [45] Chimeric MEF2D and DAZAP1 fusion proteins are created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia (ALL).
    Prima, V
    Gore, L
    Caires, A
    Boomer, T
    Yoshinari, M
    Masue, I
    Marileila, VG
    Hunger, SP
    BLOOD, 2004, 104 (11) : 159A - 159A
  • [46] A NOVEL T(9-11)(P22-Q23) WITH ALL-1 GENE REARRANGEMENT ASSOCIATED WITH PROGRESSION OF A MYELOPROLIFERATIVE DISORDER TO ACUTE MYELOID-LEUKEMIA
    NEGRINI, M
    CUNEO, A
    NAKAMURA, T
    BAFFA, R
    SABBIONI, S
    ALDER, H
    CASTOLDI, G
    CROCE, CM
    CANCER GENETICS AND CYTOGENETICS, 1995, 83 (01) : 65 - 70
  • [47] ACUTE MYELOID-LEUKEMIA WITH 11Q23 CHROMOSOME ALL-1 GENE REARRANGEMENTS DOES NOT EXHIBIT MIXED LINEAGE ANTIGEN EXPRESSION BY MULTIPARAMETER FLOW-CYTOMETRY
    BAER, MR
    STEWART, CC
    LAWRENCE, D
    ARTHUR, DC
    DAVEY, FR
    MROZEK, K
    CALIGIURI, MA
    HERZIG, GP
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1994, 84 (10) : A308 - A308
  • [48] MYELOGENOUS LEUKEMIA WITH ABNORMALITIES OF 11Q23 FOLLOWING CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PRESENTING WITH BOTH T(1-19) AND T(9-22)
    GRIFFIN, TC
    TOMLINSON, GE
    RAIMONDI, SC
    SCHNEIDER, NR
    PEDIATRIC RESEARCH, 1991, 29 (04) : A142 - A142
  • [49] Cytogenetics in B-Lineage Acute Lymphoblastic Leukemia (ALL); Translocation T (1;19) (Q23; P13.3) E2A-PBX1 is a Poor Prognostic Criterion in Children of African Descent
    Poole, J.
    Benade, E.
    Bouwer, N.
    Wiggell, T.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S140 - S140
  • [50] A plateau after 30 months of follow-up in B-lineage childhood acute lymphoblastic leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?
    Baruchel, A
    Chevret, S
    Auvrignon, A
    Ballerini, P
    Michel, G
    Gabert, J
    Vermylen, C
    Pere, Y
    Bilhou-Nabera, C
    Lejars, O
    Schmitt, C
    Jonveaux, P
    Soulier, J
    Vandenaker, J
    Auclerc, MF
    Leblanc, T
    Leverger, G
    BLOOD, 2005, 106 (11) : 416A - 416A
12345